This PDF is the current document as it appeared on Public Inspection on 03/10/2014 at 08:45 am.
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC).
The meeting will be open to the public and accessible by live webcast.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Type of meeting: Open Meeting.
Date: April 7, 2014.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*—Approximate end time.
Agenda: The purpose of this meeting is to bring together the committee members to update one another on individual agency activities undertaken in support of the Action Plan for the Muscular Dystrophies and to (a) receive an update on research in congenital muscular dystrophy (CMD), (b) hear about a new model of interacting with regulatory agencies on developing therapies for muscular dystrophy, and (c) discuss an example of partnering in developing therapies for muscular dystrophy.
An agenda is posted to the MDCC Web site: http://www.ninds.nih.gov/about_ninds/groups/mdcc/.
Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/2014_MDCC_Meeting/.
Webcast Live: For those not able to attend in person, this meeting will be webcast at: http://videocast.nih.gov/.
Place: Rockledge II Building, Conference Room 9100, 6701 Rockledge Drive, Bethesda, Maryland.
Contact Person: John D. Porter, Ph.D., Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2172, Bethesda, MD 20892, (301) 496-5739, email@example.com.
Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the Start Printed Page 13662business or professional affiliation of the interested person.
Attendance is limited to seating space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed above in advance of the meeting.
All visitors must go through a security check at the Lobby of the Rockledge II Building to receive a visitor's badge. A government issued photo ID is required.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS).Start Signature
Dated: March 5, 2014.
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-05160 Filed 3-10-14; 8:45 am]
BILLING CODE 4140-01-P